Clinical and molecuar characterization of Brazilian patients with growth hormone gene deletions

Genomic DNA from 23 patients with isolated growth hormone (GH) deficiency (12 males and 11 females: heights -4.9 ± 1.4 SDS) was screened for GH gene deletions by restriction endonuclease analysis of polymerase chain reaction amplification products. Three unrelated patients had typical features of severe GH deficiency and deletions (6.7 kb in two and 7.6 kb in one) of the GH gene. The two patients with 6.7-kb deletions developed growth-attenuating anti-GH antibodies whereas the patient with the 7.6-kb deletion continued to grow with GH replacement therapy. Our finding that 3/23 (~13%) Brazilian subjects had GH gene deletions agrees with previous studies of severe isolated GH deficiency subjects in other populations. Two of three subjects (67%) with deletions developed blocking antibodies despite administration of exogenous GH at low doses. Interestingly, only 1/10 of cases with affected relatives or parental consanguinity had GH-1 gene deletions

Endothelium-dependent vasodilation in response to Pseudomonas aeruginosa lipopolysaccharide: an in vitro study on canine arteries

Early systemic arterial hypotension is a common clinical feature of Pseudomonas septicemia. To determine if Pseudomonas aeruginosa endotoxin induces the release of endothelium-derived nitric oxide (EDNO), an endogenous nitrovasodilator, segments of canine femoral, renal, hepatic, superior mesenteric, and left circumflex coronary arteries were suspended in organ chambers (physiological salt solution, 95% O2/5% CO2, pH 7.4, 37oC) to measure isometric force. In arterial segments contracted with 2 µM prostaglandin F2a, Pseudomonas endotoxin (lipopolysaccharide (LPS) serotype 10(Habs) from Pseudomonas aeruginosa (0.05 to 0.50 mg/ml)) induced concentration-dependent relaxation of segments with endothelium (P<0.05) but no significant change in tension of arteries without endothelium. Endothelium-dependent relaxation in response to Pseudomonas LPS occurred in the presence of 1 µM indomethacin, but could be blocked in the coronary artery with 10 µM NG-monomethyl-L-arginine (L-NMMA), a competitive inhibitor of nitric oxide synthesis from L-arginine. The inhibitory effect of L-NMMA on LPS-mediated vasorelaxation of the coronary artery could be reversed by exogenous 100 µM L-arginine but not by 100 µM D-arginine. These experiments indicate that Pseudomonas endotoxin induces synthesis of nitric oxide from L-arginine by the vascular endothelium. LPS-mediated production of EDNO by the endothelium, possibly through the action of constitutive nitric oxide synthase (NOSc), may decrease systemic vascular resistance and may be the mechanism of early hypotension characteristic of Pseudomonas septicemia.

Insulin receptor has tyrosine kinase activity toward Shc in rat liver

Insulin induces tyrosine phosphorylation of Shc in cell cultures and in insulin-sensitive tissues of the intact rat. However, the ability of insulin receptor (IR) tyrosine kinase to phosphorylate Shc has not been previously demonstrated. In the present study, we investigated insulin-induced IR tyrosine kinase activity towards Shc. Insulin receptor was immunoprecipitated from liver extracts, before and after a very low dose of insulin into the portal vein, and incubated with immunopurified Shc from liver of untreated rats. The kinase assay was performed in vitro in the presence of exogenous ATP and the phosphorylation level was quantified by immunoblotting with antiphosphotyrosine antibody. The results demonstrate that Shc interacted with insulin receptor after infusion of insulin, and, more important, there was insulin receptor kinase activity towards immunopurified Shc. The description of this pathway in animal tissue may have an important role in insulin receptor tyrosine kinase activity toward mitogenic transduction pathways.

Induction of apoptosis in cancer cells by tumor necrosis factor and butyrolactone, an inhibitor of cyclin-dependent kinases

Induction of apoptosis by tumor necrosis factor (TNF) is modulated by changes in the expression and activity of several cell cycle regulatory proteins. We examined the effects of TNF (1-100 ng/ml) and butyrolactone I (100 µM), a specific inhibitor of cyclin-dependent kinases (CDK) with high selectivity for CDK-1 and CDK-2, on three different cancer cell lines: WEHI, L929 and HeLa S3. Both compounds blocked cell growth, but only TNF induced the common events of apoptosis, i.e., chromatin condensation and ladder pattern of DNA fragmentation in these cell lines. The TNF-induced apoptosis events were increased in the presence of butyrolactone. In vitro phosphorylation assays for exogenous histone H1 and endogenous retinoblastoma protein (pRb) in the total cell lysates showed that treatment with both TNF and butyrolactone inhibited the histone H1 kinase (WEHI, L929 and HeLa) and pRb kinase (WEHI) activities of CDKs, as compared with the controls. The role of proteases in the TNF and butyrolactone-induced apoptosis was evaluated by comparing the number and expression of polypeptides in the cell lysates by gel electrophoresis. TNF and butyrolactone treatment caused the disappearance of several cellular protein bands in the region between 40-200 kDa, and the 110- 90- and 50-kDa proteins were identified as the major substrates, whose degradation was remarkably increased by the treatments. Interestingly, the loss of several cellular protein bands was associated with the marked accumulation of two proteins apparently of 60 and 70 kDa, which may be cleavage products of one or more proteins. These findings link the decrease of cyclin-dependent kinase activities to the increase of protease activities within the growth arrest and apoptosis pathways induced by TNF.

Magnesium chloride alone or in combination with diazepam fails to prevent hippocampal damage following transient forebrain ischemia

In the central nervous system, magnesium ion (Mg2+) acts as an endogenous modulator of N-methyl-D-aspartate (NMDA)-coupled calcium channels, and may play a major role in the pathomechanisms of ischemic brain damage. In the present study, we investigated the effects of magnesium chloride (MgCl2, 2.5, 5.0 or 7.5 mmol/kg), either alone or in combination with diazepam (DZ), on ischemia-induced hippocampal cell death. Male Wistar rats (250-300 g) were subjected to transient forebrain ischemia for 15 min using the 4-vessel occlusion model. MgCl2 was applied systemically (sc) in single (1x, 2 h post-ischemia) or multiple doses (4x, 1, 2, 24 and 48 h post-ischemia). DZ was always given twice, at 1 and 2 h post-ischemia. Thus, ischemia-subjected rats were assigned to one of the following treatments: vehicle (0.1 ml/kg, N = 34), DZ (10 mg/kg, N = 24), MgCl2 (2.5 mmol/kg, N = 10), MgCl2 (5.0 mmol/kg, N = 17), MgCl2 (7.5 mmol/kg, N = 9) or MgCl2 (5 mmol/kg) + DZ (10 mg/kg, N = 14). Seven days after ischemia the brains were analyzed histologically. Fifteen minutes of ischemia caused massive pyramidal cell loss in the subiculum (90.3%) and CA1 (88.4%) sectors of the hippocampus (P<0.0001, vehicle vs sham). Compared to the vehicle-treated group, all pharmacological treatments failed to attenuate the ischemia-induced death of both subiculum (lesion: 86.7-93.4%) and CA1 (lesion: 85.5-91.2%) pyramidal cells (P>0.05). Both DZ alone and DZ + MgCl2 reduced rectal temperature significantly (P<0.05). No animal death was observed after drug treatment. These data indicate that exogenous magnesium, when administered systemically post-ischemia even in different multiple dose schedules, alone or with diazepam, is not useful against the histopathological effects of transient global cerebral ischemia in rats.

The physiological role of AT1 receptors in the ventrolateral medulla

Neurons in the rostral and caudal parts of the ventrolateral medulla (VLM) play a pivotal role in the regulation of sympathetic vasomotor activity and blood pressure. Studies in several species, including humans, have shown that these regions contain a high density of AT1 receptors specifically associated with neurons that regulate the sympathetic vasomotor outflow, or the secretion of vasopressin from the hypothalamus. It is well established that specific activation of AT1 receptors by application of exogenous angiotensin II in the rostral and caudal VLM excites sympathoexcitatory and sympathoinhibitory neurons, respectively, but the physiological role of these receptors in the normal synaptic regulation of VLM neurons is not known. In this paper we review studies which have defined the effects of specific activation or blockade of these receptors on cardiovascular function, and discuss what these findings tell us with regard to the physiological role of AT1 receptors in the VLM in the tonic and phasic regulation of sympathetic vasomotor activity and blood pressure.

A study of the interaction between Helicobacter pylori and components of the human fibrinolytic system

The interaction of plasminogen, tissue plasminogen activator (t-PA) and urokinase with a clinical strain of Helicobacter pylori was studied. Plasminogen bound to the surface of H. pylori cells in a concentration-dependent manner and could be activated to the enzymatic form, plasmin, by t-PA. Affinity chromatography assays revealed a plasminogen-binding protein of 58.9 kDa in water extracts of surface proteins. Surface-associated plasmin activity, detected with the chromogenic substrate CBS 00.65, was observed only when plasminogen and an exogenous activator were added to the cell suspension. The two physiologic plasminogen activators, t-PA and urokinase, were also shown to bind to and remain active on the surface of bacterial cells. epsilon-Aminocaproic acid caused partial inhibition of t-PA binding, suggesting that the kringle 2 structure of this activator is involved in the interaction with surface receptors. The activation of plasminogen by t-PA, but not urokinase, strongly depended on the presence of cells and a 25-fold enhancer effect on the initial velocity of activation by t-PA compared to urokinase was established. Furthermore, a relationship between cell concentration and the initial velocity of activation was demonstrated. These findings support the concept that plasminogen activation by t-PA on the bacterial surface is a surface-dependent reaction which offers catalytic advantages.

Production, isolation and characterization of bioactive peptides with antihypertensive properties from rapeseed and potato protein

Consumers’ increasing awareness of healthiness and sustainability of food presents a great challenge to food industry to develop healthier, biologically active and sustainable food products. Bioactive peptides derived from food proteins are known to possess various biological activities. Among the activities, the most widely studied are antioxidant activities and angiotensin I converting enzyme (ACE) inhibitory activity related to blood pressure regulation and antihypertensive effects. Meanwhile, vast amounts of byproducts with high protein content are produced in food industry, for example potato and rapeseed industries. The utilization of these by-products could be enhanced by using them as a raw material for bioactive peptides. The objective of the present study was to investigate the production of bioactive peptides with ACE inhibitory and antioxidant properties from rapeseed and potato proteins. Enzymatic hydrolysis and fermentation were utilized for peptide production, ultrafiltration and solid-phase extraction were used to concentrate the active peptides, the peptides were fractionated with liquid chromatographic processes, and the peptides with the highest ACE inhibitory capacities were putified and analyzed with Maldi-Tof/Tof to identify the active peptide sequences. The bioavailability of the ACE inhibitory peptides was elucidated with an in vitro digestion model and the antihypertensive effects in vivo of rapeseed peptide concentrates were investigated with a preventive premise in 2K1C rats. The results showed that rapeseed and potato proteins are rich sources of ACE inhibitory and antioxidant peptides. Enzymatic hydrolysis released the peptides effectively whereas fermentation produced lower activities.The native enzymes of potato were also able to release ACE inhibitory peptides from potato proteins without the addition of exogenous enzymes. The rapeseed peptide concentrate was capable of preventing the development of hypertension in vivo in 2K1C rats, but the quality of rapeseed meal used as raw material was found to affect considerably the antihypertensive effects and the composition of the peptide fraction.

Familial hyperaldosteronism

Aldosterone, the major circulating mineralocorticoid, participates in blood volume and serum potassium homeostasis. Primary aldosteronism is a disorder characterised by hypertension and hypokalaemia due to autonomous aldosterone secretion from the adrenocortical zona glomerulosa. Improved screening techniques, particularly application of the plasma aldosterone:plasma renin activity ratio, have led to a suggestion that primary aldosteronism may be more common than previously appreciated among adults with hypertension. Glucocorticoid-remediable aldosteronism (GRA) was the first described familial form of hyperaldosteronism. The disorder is characterised by aldosterone secretory function regulated chronically by ACTH. Hence, aldosterone hypersecretion can be suppressed, on a sustained basis, by exogenous glucocorticoids such as dexamethasone in physiologic range doses. This autosomal dominant disorder has been shown to be caused by a hybrid gene mutation formed by a crossover of genetic material between the ACTH-responsive regulatory portion of the 11ß-hydroxylase (CYP11B1) gene and the coding region of the aldosterone synthase (CYP11B2) gene. Familial hyperaldosteronism type II (FH-II), so named to distinguish the disorder from GRA or familial hyperaldosteronism type I (FH-I), is characterised by autosomal dominant inheritance of autonomous aldosterone hypersecretion which is not suppressible by dexamethasone. Linkage analysis in a single large kindred, and direct mutation screening, has shown that this disorder is unrelated to mutations in the genes for aldosterone synthase or the angiotensin II receptor. The precise genetic cause of FH-II remains to be elucidated.

Coronary endothelial dysfunction after ischemia and reperfusion: a new therapeutic target?

Although cardiac ischemia is usually characterized as a disease of the myocyte, it is clear that the vasculature, and especially endothelial cells, is also a major target of this pathology. Indeed, using a rat model of ischemia/reperfusion, we were able to detect severe endothelial dysfunction (assessed as a decreased response to acetylcholine) after acute or chronic reperfusion. Given the essential role of the endothelium in the regulation of vascular tone, as well as platelet and leukocyte function, such a severe dysfunction could lead to an increased risk of vasospasm, thrombosis and accelerated atherosclerosis. This dysfunction can be prevented by free radical scavengers and by exogenous nitric oxide. Endothelial dysfunction can also be prevented by preconditioning with brief periods of intermittent ischemia, thus extending to coronary endothelial cells the concept of endogenous protection previously described at the myocyte level. Experiments performed on cultured cells showed that the endothelial protection induced by free radical scavengers or by preconditioning was due to a lesser expression of endothelial adhesion molecules such as intercellular adhesion molecule-1, leading to a lesser adhesion of neutrophils to endothelial cells. Identification of the mechanisms of this protection may lead to the development of new strategies aimed at protecting the vasculature in ischemic heart diseases.

The modulatory effect of estradiol benzoate on superoxide dismutase activity in the developing rat brain

The sensitivity of copper,zinc (CuZn)- and manganese (Mn)-superoxide dismutase (SOD) to exogenous estradiol benzoate (EB) was investigated in Wistar rats during postnatal brain development. Enzyme activities were measured in samples prepared from brains of rats of both sexes and various ages between 0 and 75 days, treated sc with 0.5 µg EB/100 g body weight in 0.1 ml olive oil/100 g body weight, 48 and 24 h before sacrifice. In females, EB treatment stimulated MnSOD activity on days 0 (66.1%), 8 (72.7%) and 15 (81.7%). In males, the stimulatory effect of EB on MnSOD activity on day 0 (113.6%) disappeared on day 8 and on days 15 and 45 it became inhibitory (40.3 and 30.5%, respectively). EB had no effect on the other age groups. The stimulatory effect of EB on CuZnSOD activity in newborn females (51.8%) changed to an inhibitory effect on day 8 (38.4%) and disappeared by day 45 when inhibition was detected again (48.7%). In males, the inhibitory effect on this enzyme was observed on days 0 (45.0%) and 15 (28.9%), and then disappeared until day 60 when a stimulatory effect was observed (38.4%). EB treatment had no effect on the other age groups. The sensitivity of MnSOD to estradiol differed significantly between sexes during the neonatal and prepubertal period, whereas it followed a similar pattern thereafter. The sensitivity of CuZnSOD to estradiol differed significantly between sexes during most of the study period. Regression analysis showed that the sensitivity of MnSOD to this estrogen tended to decrease similarly in both sexes, whereas the sensitivity of CuZnSOD showed a significantly different opposite tendency in female and male rats. These are the first reports indicating hormonal modulation of antioxidant enzyme activities related to the developmental process.

Shared control of maltose and trehalose utilization in Candida utilis

Trehalose biosynthesis and its hydrolysis have been extensively studied in yeast, but few reports have addressed the catabolism of exogenously supplied trehalose. Here we report the catabolism of exogenous trehalose by Candida utilis. In contrast to the biphasic growth in glucose, the growth of C. utilis in a mineral medium with trehalose as the sole carbon and energy source is aerobic and exhibits the Kluyver effect. Trehalose is transported into the cell by an inducible trehalose transporter (K M of 8 mM and V MAX of 1.8 µmol trehalose min-1 mg cell (dry weight)-1. The activity of the trehalose transporter is high in cells growing in media containing trehalose or maltose and very low or absent during the growth in glucose or glycerol. Similarly, total trehalase activity was increased from about 1.0 mU/mg protein in cells growing in glucose to 39.0 and 56.2 mU/mg protein in cells growing in maltose and trehalose, respectively. Acidic and neutral trehalase activities increased during the growth in trehalose, with neutral trehalase contributing to about 70% of the total activity. In addition to the increased activities of the trehalose transporter and trehalases, growth in trehalose promoted the increase in the activity of alpha-glucosidase and the maltose transporter. These results clearly indicate that maltose and trehalose promote the increase of the enzymatic activities necessary to their catabolism but are also able to stimulate each other's catabolism, as reported to occur in Escherichia coli. We show here for the first time that trehalose induces the catabolism of maltose in yeast.

Sulfated proteoglycans as modulators of neuronal migration and axonal decussation in the developing midbrain

Proteoglycans are abundant in the developing brain and there is much circumstantial evidence for their roles in directional neuronal movements such as cell body migration and axonal growth. We have developed an in vitro model of astrocyte cultures of the lateral and medial sectors of the embryonic mouse midbrain, that differ in their ability to support neuritic growth of young midbrain neurons, and we have searched for the role of interactive proteins and proteoglycans in this model. Neurite production in co-cultures reveals that, irrespective of the previous location of neurons in the midbrain, medial astrocytes exert an inhibitory or nonpermissive effect on neuritic growth that is correlated to a higher content of both heparan and chondroitin sulfates (HS and CS). Treatment of astrocytes with chondroitinase ABC revealed a growth-promoting effect of CS on lateral glia but treatment with exogenous CS-4 indicated a U-shaped dose-response curve for CS. In contrast, the growth-inhibitory action of medial astrocytes was reversed by exogenous CS-4. Treatment of astrocytes with heparitinase indicated that the growth-inhibitory action of medial astrocytes may depend heavily on HS by an as yet unknown mechanism. The results are discussed in terms of available knowledge on the binding of HS proteoglycans to interactive proteins, with emphasis on the importance of unraveling the physiological functions of glial glycoconjugates for a better understanding of neuron-glial interactions.

Early effects of estrogen on the rat ventral prostate

Complex interactions between androgen and estrogen (E2) regulate prostatic development and physiology. We analyzed the early effects of a high single dose of E2 (25 mg/kg body weight) and castration (separately or combined) on the adult 90-day-old male Wistar rat ventral prostate. Androgen levels, prostate weight, and the variation in the relative and absolute volume of tissue compartments and apoptotic indices were determined for 7 days. Castration and exogenous E2 markedly reduced ventral prostate weight (about 50% of the control), with a significant reduction in the epithelial compartment and increased stroma. The final volume of the epithelium was identical at day 7 for all treatments (58.5% of the control). However, E2 had an immediate effect, causing a reduction in epithelial volume as early as day 1. An increase in smooth muscle cell volume resulted from the concentration of these cells around the regressing epithelium. The treatments resulted in differential kinetics in epithelial cell apoptosis. Castration led to a peak in apoptosis at day 3, with 5% of the epithelial cells presenting signs of apoptosis, whereas E2 caused an immediate increase (observed on day 1) and a sustained (up to day 7) effect. E2 administration to castrated rats significantly increased the level of apoptosis by day 3, reaching 9% of the epithelial cells. The divergent kinetics between treatments resulted in the same levels of epithelial regression after 7 days (~30% of control). These results show that E2 has an immediate and possibly direct effect on the prostate, and anticipates epithelial cell death before reducing testosterone to levels as low as those of castrated rats. In addition, E2 and androgen deprivation apparently cause epithelial cell death by distinct and independent pathways.

Suomen mahdollisuudet vaikuttaa Euroopan unionin lainsäädäntömenettelyyn

Väitöstutkimuksen kohteena on säädösten valmistelu ja niitä koskevaa päätöksenteko Euroopan unionissa erityisesti siitä näkökulmasta, miten Suomen kaltainen pieni jäsenvaltio voi vaikuttaa EU-säädöksiin. Väitöskirjassa analysoidaan unionin toimielinten välillä vallitsevaa dynamiikkaa ja Suomen asemaa erityisesti EUT-sopimuksen 289 artiklan 1 kohdan ja 294 artiklan mukaisessa tavallisessa lainsäätämisjärjestyksessä. Lissabonin sopimuksen voimaantulon jälkeen tavallinen lainsäätämisjärjestys, joka aiemmin tunnettiin yhteispäätösmenettelynä, on selvästi yleisin lainsäädäntömenettely unionissa. Väitöskirja koostuu kuudesta erillisjulkaistusta pääosin vertaisarvioidusta artikkelista ja niitä täydentävästä ja kokoavasta yhteenveto-osasta. Kirjan tämä painos sisältää vain yhteenvetoluvun, ei erikseen julkaistuja artikkeleita. Väitöskirjassa hyödynnetään eurooppaoikeuden ja politiikan tutkimuksen kirjallisuutta. Metodologisesti väitöstutkimus edustaa empiiristä oikeustutkimusta, jossa yhdistyy lainopillinen analyysi ja empiiristen, tässä tapauksessa lähinnä laadullisten aineistojen analyysi. Yhteenvedossa on seurattu lainsäädäntömuutoksia ja oikeuskäytäntöä 10. huhtikuuta 2015 asti. Väitöskirjatutkimuksen kantavana teemana on oikeuden ja politiikan suhde EUlainsäätämisessä. Artikkeleita ja yhteenvetoa sitovat yhteen kaksi yleisen tason argumenttia. Ensiksi, EU:n lainsäädäntömenettelyä koskevat oikeussäännöt ja institutionalisoituneet käytännöt luovat kehikon toimielinten sisäiselle päätöksenteolle sekä niiden välisille poliittisluonteisille neuvotteluille, vaikkakaan sääntöihin ja käytäntöihin ei yleensä ole tarvetta nimenomaisesti vedota menettelyn kuluessa. Toiseksi, koska Suomen kaltaisen pienen jäsenvaltion muodollinen valta – siis äänimäärä neuvostossa – on hyvin rajallinen, suomalaisten ministerien ja virkamiesten tulisi hyödyntää erilaisia epävirallisia vaikuttamiskanavia, jos halutaan vahvistaa Suomen tosiasiallista vaikutusvaltaa menettelyssä. Unionin lainsäädäntötoiminta ei tyypillisesti ole rationaalisen mallin mukaan etenevää päätöksentekoa, vaan tempoilevaa ja vaikeasti ennakoitavaa kamppailua eri preferenssejä edustavien toimijoiden välillä. Väitöskirjan ensimmäisessä artikkelissa analysoidaan säädösvalmistelua ja lainsäätämismenettelyä unionissa vaihe vaiheelta. Johtopäätöksenä todetaan, että unioniin on syntynyt yhteispäätösmenettelyn, sittemmin tavallisen lainsäätämisjärjestyksen myötä uudenlainen lainsäätämiskulttuuri, jolle on leimallista tiiviit yhteydet komission, Euroopan parlamentin ja neuvoston välillä. Toimielimet ottavat nykyisin joustavasti huomioon toistensa kantoja menettelyn edetessä, mikä mahdollistaa sen, että valtaosa EU-säädöksistä voidaan hyväksyä jo ensimmäisessä käsittelyssä. Toisessa tutkimusartikkelissa analysoidaan komission asemaa unionin toimielinrakenteessa. Artikkelissa tarkastellaan komission aloiteoikeutta sekä komission puheenjohtajan ja sen jäsenten valintamenettelyjä siitä näkökulmasta, edistääkö komissio todella unionin yleistä etua itsenäisenä ja riippumattomana, kuten EU-sopimuksen 17 artiklassa edellytetään. Tiettyjen järjestelyjen myötä Euroopan parlamentin ja komission suhde on kehittynyt siihen suuntaan, että komissio toimii jossain määrin parlamentille vastuunalaisena hallituksena. Artikkelissa kritisoidaan, että kehitys ei välttämättä lähennä kansalaisia unionin toimielimiin ja että kehitys omiaan vaarantamaan komission aseman verrattain riippumattomana välittäjänä trilogeissa. Kolmas artikkeli sisältää tapaustutkimuksen kuluttajille myönnettäviä luottoja sääntelevän direktiivin (2008/48/EY) valmisteluvaiheista. Tapaustutkimus konkretisoi Suomen hallituksen edustajien tekemän EU-vaikuttamisen keinoja, vahvuuksia ja kehittämiskohteita. Artikkelissa todetaan, että Suomelle aivan keskeinen vaikuttamisresurssi ovat sellaiset virkamiehet, jotka hallitsevat niin käsiteltävän säädöshankkeen sisältökysymykset kuin unionin päätöksentekomenettelyt ja toimielinten institutionalisoituneet käytännöt. Artikkelissa tehdyt empiiriset havainnot jäsenvaltioiden välillä käydyistä neuvotteluista tukevat konstruktiivisen mallin perusoletuksia. Neljännessä artikkelissa, joka on laadittu yhteistyönä professori Tapio Raunion kanssa, analysoidaan unioniasioiden kansallista valmistelua ja tarkemmin ottaen sitä, miten Suomen neuvottelukannat muotoutuvat valtioneuvoston yhteensovittamisjärjestelmän ylimmällä tasolla EU-ministerivaliokunnassa. Artikkelissa todetaan laajan pöytäkirja-aineiston ja sitä täydentävän haastatteluaineiston pohjalta, että EUministerivaliokunnan asialistan laadinta on delegoitu kokonaisuudessaan asiantuntijavirkamiehille. Lisäksi asialistan muotoutumiseen vaikuttaa luonnollisesti unionin toimielinten, erityisesti Eurooppa-neuvoston agenda. Toisaalta, EU-ministerivaliokunnan kokouksissa ministerit yksin tekevät päätöksiä ja linjaavat Suomen EU-politiikkaa. Viidennessä artikkelissa selvitetään, miten olisi toimittava, jos pyritään siihen, että uusi tai muutettu EU-säädös vastaisi mahdollisimman pitkälti Suomen kansallisesti määriteltyä neuvottelukantaa. Tehokkainta on vaikuttaa aloiteoikeutta lainsäädäntömenettelyssä käyttävään komissioon, tarvittaessa myös virkahierarkian ylimmillä tasoilla, sekä tehdä yhteistyötä muiden jäsenvaltioiden kanssa, erityisesti puheenjohtajavaltion, tulevien puheenjohtajavaltioiden ja suurten jäsenvaltioiden kanssa. Mikäli käsittelyssä oleva EU-säädöshanke arvioidaan kansallisesti erityisen tärkeiksi tai ongelmalliseksi, tulisi vaikuttamistoimia laajentaa kattamaan myös Euroopan parlamentin avainhenkilöitä. Kuudennessa artikkelissa analysoidaan suomalaisen kansalaisyhteiskunnan ja etujärjestöjen vaikutusmahdollisuuksia EU-asioiden valmistelussa. Johtopäätöksenä todetaan, että muodollinen yhteensovittaminen EU-valmistelujaostojen laajan kokoonpanon kokouksissa ei ole sidosryhmille ensisijainen eikä tehokkain vaikuttamisen keino. Sen sijaan korostuvat epäviralliset yhteydet toimivaltaisen ministeriön vastuuvirkamieheen kotimaassa ja vaikuttaminen eurooppalaisen kattojärjestön välityksellä. Väitöskirjan yhteenveto-osassa on eritelty, missä EU:n säädösvalmistelun ja lainsäätämismenettelyn vaiheissa Suomen kaltaisella pienellä jäsenvaltiolla on parhaat edellytykset vaikuttaa valmisteltavana olevaan säädökseen. Parhaat vaikutusmahdollisuudet ovat aivan EU-säädöksen elinkaaren alkuvaiheessa, kun komissio on vasta käynnistämässä uutta säädösvalmistelua. Väitöstutkimuksessa todetaan, että varhaista kannanmuodostusta ja sen mahdollistamaa ennakkovaikuttamista on Suomessa kyetty kehittämään etenkin niissä poliittisesti, taloudellisesti tai oikeudellisesti tärkeissä hankkeissa, joissa hallituksen kannanmuodostus tapahtuu EU-ministerivaliokunnassa. Muissa unionin säädöshankkeissa ennakollisen vaikuttamisen intensiteetti näyttäisi vaihtelevan, riippuen muun muassa toimivaltaisen ministeriön keskijohdon ja ylimmän johdon sitoutumisesta. Toinen Suomelle otollinen vaikuttamisen ajankohta on silloin, kun komission antamaa ehdotusta käsitellään asiantuntijavirkamiesten kesken neuvoston työryhmässä. Tehokas vaikuttaminen edellyttää, että Suomea neuvotteluissa edustavat henkilöt kokoavat ”samanmielisistä” jäsenvaltioista kaksoisenemmistösäännön mukaisen voittavan koalition. Viimeinen vaikuttamisen ikkuna aukeaa silloin, kun Coreper-komiteassa laaditaan neuvoston puheenjohtajalle neuvottelumandaattia toimielinten välisiin trilogeihin tavallisen lainsäätämisjärjestyksen ensimmäisessä käsittelyssä. Tässä varsin myöhäisessä menettelyvaiheessa vaikuttaminen on pienen jäsenvaltion näkökulmasta jo selvästi vaikeampaa. Väitöskirja sijoittuu luontevasti osaksi valtiotieteellistä eurooppalaistumis-kirjallisuutta siltä osin, kuin siinä on tutkittu EU-jäsenyyden vaikutuksia kotimaisiin hallinnon rakenteisiin ja politiikan asialistaan. Kuten tunnettua, Suomen EU-politiikka rakentuu eduskunnalle vastuullisen valtioneuvoston varaan. Väitöskirjassa ei kuitenkaan ole otettu erityiseen tarkasteluun perustuslakiin sidottua eduskunnan ja hallituksen yhteistoimintaa EU-asioissa. Sen sijaan on tutkittu unioniasioiden valmistelua ja yhteensovittamista valtioneuvoston sisällä. Kun EU-asioiden yhteensovittamisjärjestelmää luotiin, pidettiin tärkeänä, että jokaisessa säädöshankkeessa ja politiikkahankkeessa kyetään muodostamaan kansallisesti yksi ja yhtenäinen neuvottelupositio. Yhtenäisen kansallisen linjan ajamisen katsottiin parantavan Suomen asemaa unionin päätöksenteossa. Väitöskirjassa todetaan johtopäätöksenä, että EU-asioiden kansallinen valmistelujärjestelmä toteuttaa sille asetetut tavoitteet käytännössä varsin hyvin. Merkittävin kehittämiskohde liittyy kansallisen EU-valmistelun reaktiivisuuteen. Jos Suomi haluaa vaikuttaa yhä vahvemmin EU-lainsäätämiseen, Suomelle tärkeät hankkeet pitäisi tunnistaa jo varhaisessa vaiheessa ja priorisoida selkeästi niiden hoitamista ministeriöissä.